Error: Could not add to watchlist. X

Candriam Equities L Biotechnology

+ Watchlist
DEXEBTC:LX
543.76
USD
14.04
2.52%
As of 00:59:30 ET on 09/01/2015.
Fund Type
SICAV
52Wk Range
420.72 - 651.80
1 Yr Return
19.32%
YTD Return
6.37%
Previous Close
557.80
52Wk Range
420.72 - 651.80
1 Yr Return
19.32%
YTD Return
6.37%
Fund Type
SICAV
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
International
NAV (on 09/01/2015)
543.76
Total Assets (m USD) (on 09/01/2015)
772.199
Inception Date
04/06/2000
Last Dividend (on -)
-
Dividend Indicated Gross Yield
-
Fund Managers
RUDI VAN DEN EYNDE
Front Load Fee
3.50%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
1.50%
Expense Ratio
1.77%
Top Fund Holdings
Name Position Value % of Fund
Gilead Sciences Inc 588.00 k 69.30 m 7.70
Celgene Corp 521.00 k 68.38 m 7.60
Amgen Inc 353.00 k 62.34 m 6.93
Regeneron Pharmaceuticals Inc 108.00 k 59.80 m 6.64
Biogen Inc 159.50 k 50.85 m 5.65
Alexion Pharmaceuticals Inc 170.00 k 33.56 m 3.73
Vertex Pharmaceuticals Inc 248.00 k 33.48 m 3.72
BioMarin Pharmaceutical Inc 198.00 k 28.96 m 3.22
Incyte Corp 247.00 k 25.76 m 2.86
Illumina Inc 89.00 k 19.52 m 2.17
Profile
Candriam Equities L - Biotechnology is a SICAV incorporated under the laws of Luxembourg. The Fund's objective is capital appreciation. The Fund invests in global biotechnology stocks. Because the sector is currently experiencing the highest growth in the U.S., at least two-thirds of the Fund's assets will be invested in U.S. biotechnology stocks.
ADDRESS
Candriam Luxembourg
136 route d'Arlon
1150 Luxembourg
PHONE
352-254-3431